The mechanism is yet to be fully described, though several signaling pathways and factors were shown be involved, such as MUC1 in AML cells [146] and activation of Akt/mTOR pathway via TLR2 (toll-like receptor 2) in MDSC [145]. The gene discussed is TLR2; the disease is acute myeloid leukemia.